Found: 75
Select item for more details and to access through your institution.
Expression of Programmed Cell Death Ligand in Cutaneous Squamous Cell Carcinoma and Treatment of Locally Advanced Disease With Pembrolizumab.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Hedgehog Pathway Blockade Inhibits Melanoma Cell Growth in Vitro and in Vivo.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 11, p. 1429, doi. 10.3390/ph6111429
- By:
- Publication type:
- Article
Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00974-z
- By:
- Publication type:
- Article
A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 103, doi. 10.1007/s10637-017-0530-4
- By:
- Publication type:
- Article
A phase I dose-escalation study of TAK-733, an investigational oral MEK inhibitor, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 1, p. 47, doi. 10.1007/s10637-016-0391-2
- By:
- Publication type:
- Article
A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 4, p. 439, doi. 10.1007/s10637-016-0348-5
- By:
- Publication type:
- Article
Intra- and Inter-Tumor Heterogeneity of BRAF<sup>V600E</sup>Mutations in Primary and Metastatic Melanoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0029336
- By:
- Publication type:
- Article
The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0025264
- By:
- Publication type:
- Article
A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates.
- Published in:
- PLoS ONE, 2010, v. 5, n. 12, p. 1, doi. 10.1371/journal.pone.0015588
- By:
- Publication type:
- Article
A Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) in Patients with Metastatic Melanoma.
- Published in:
- PLoS ONE, 2010, v. 5, n. 1, p. 1, doi. 10.1371/journal.pone.0008714
- By:
- Publication type:
- Article
Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03697-3
- By:
- Publication type:
- Article
Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 6, p. 897, doi. 10.1007/s00262-019-02318-8
- By:
- Publication type:
- Article
Current concepts and approaches to merkel cell carcinoma.
- Published in:
- Archives of Dermatological Research, 2021, v. 313, n. 3, p. 129, doi. 10.1007/s00403-020-02107-9
- By:
- Publication type:
- Article
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 2, p. 425, doi. 10.1007/s10637-012-9862-2
- By:
- Publication type:
- Article
Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 3, p. 1074, doi. 10.1007/s10637-011-9639-z
- By:
- Publication type:
- Article
A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
A pilot phase II trial of all- trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 6, p. 1482, doi. 10.1007/s10637-010-9478-3
- By:
- Publication type:
- Article
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 3, p. 489, doi. 10.1007/s10637-009-9376-8
- By:
- Publication type:
- Article
Radiation-Related Cancer Risk Associated With Radiographic Imaging.
- Published in:
- JAMA Ophthalmology, 2013, v. 131, n. 9, p. 1248, doi. 10.1001/jamaophthalmol.2013.4025
- By:
- Publication type:
- Article
Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM).
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-46665-z
- By:
- Publication type:
- Article
Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204).
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1961, doi. 10.1093/neuonc/noab094
- By:
- Publication type:
- Article
Challenging the current paradigm of melanoma progression: brain metastasis as isolated first visceral site.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 7, p. 849
- By:
- Publication type:
- Article
Significant Survival Improvements for Patients with Melanoma Brain Metastases: Can We Reach Cure in the Current Era?
- Published in:
- Journal of Radiosurgery & SBRT, 2022, v. 8, p. 25
- By:
- Publication type:
- Article
Update on Vaccines for High-Risk Melanoma.
- Published in:
- Current Treatment Options in Oncology, 2014, v. 15, n. 2, p. 269, doi. 10.1007/s11864-014-0283-7
- By:
- Publication type:
- Article
Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanoma.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase II Trial of Dacarbazine and Thalidomide for the Treatment of Metastatic Melanoma.
- Published in:
- Chemotherapy (0009-3157), 2009, v. 55, n. 4, p. 221, doi. 10.1159/000219435
- By:
- Publication type:
- Article
MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 450, p. 1, doi. 10.1126/scitranslmed.aar3342
- By:
- Publication type:
- Article
Histology-Specific MicroRNA Alterations in Melanoma.
- Published in:
- Journal of Investigative Dermatology, 2012, v. 132, n. 7, p. 1860, doi. 10.1038/jid.2011.451
- By:
- Publication type:
- Article
Deletion of PTENP1 Pseudogene in Human Melanoma.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy.
- Published in:
- Journal of Surgical Oncology, 2020, v. 122, n. 3, p. 555, doi. 10.1002/jso.25987
- By:
- Publication type:
- Article
Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 15, doi. 10.1007/s00280-023-04544-5
- By:
- Publication type:
- Article
Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 183, doi. 10.1007/s00280-012-1995-7
- By:
- Publication type:
- Article
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 4, p. 803, doi. 10.1007/s00280-009-0931-y
- By:
- Publication type:
- Article
A multidisciplinary management algorithm for brain metastases.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac176
- By:
- Publication type:
- Article
A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma.
- Published in:
- 2015
- By:
- Publication type:
- Abstract
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 316, doi. 10.1186/s12967-014-0342-7
- By:
- Publication type:
- Article
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Melanoma risk loci as determinants of melanoma recurrence and survival.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-279
- By:
- Publication type:
- Article
Melanoma risk loci as determinants of melanoma recurrence and survival.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Serum microRNAs as biomarkers for recurrence in melanoma.
- Published in:
- Journal of Translational Medicine, 2012, v. 10, n. 1, p. 155, doi. 10.1186/1479-5876-10-155
- By:
- Publication type:
- Article
Incidence of the V600K mutation amongmelanoma patients with BRAF mutations, andpotential therapeutic response to the specificBRAF inhibitor PLX4032.
- Published in:
- Journal of Translational Medicine, 2010, v. 8, p. 67, doi. 10.1186/1479-5876-8-67
- By:
- Publication type:
- Article
Clinical relevance of Neutral Endopeptidase (NEP/CD10) in melanoma.
- Published in:
- Journal of Translational Medicine, 2007, v. 5, p. 2, doi. 10.1186/1479-5876-5-2
- By:
- Publication type:
- Article
Decreased cytotoxic T cells and TCR clonality in organ transplant recipients with squamous cell carcinoma.
- Published in:
- NPJ Precision Oncology, 2020, v. 4, n. 1, p. 1, doi. 10.1038/s41698-020-0119-9
- By:
- Publication type:
- Article
Impact of Socioeconomic Status and Sociodemographic Factors on Melanoma Presentation Among Ethnic Minorities.
- Published in:
- Journal of Community Health, 2011, v. 36, n. 3, p. 461, doi. 10.1007/s10900-010-9328-4
- By:
- Publication type:
- Article
Ipsilateral metastatic choroidal melanoma responds to systemic immunotherapy.
- Published in:
- European Journal of Ophthalmology, 2020, v. 30, n. 5, p. NP69, doi. 10.1177/1120672119839925
- By:
- Publication type:
- Article
Systemic bevacizumab (Avastin) for exudative retinal detachment secondary to choroidal melanoma.
- Published in:
- European Journal of Ophthalmology, 2011, v. 21, n. 6, p. 796, doi. 10.5301/EJO.2011.6477
- By:
- Publication type:
- Article
A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 8, p. 1711, doi. 10.1002/cncr.25643
- By:
- Publication type:
- Article
Meta-analysis of sentinel lymph node positivity in thin melanoma (<or=1 mm).
- Published in:
- 2009
- By:
- Publication type:
- journal article